Mad in America

APRIL 27, 2024

This was a story of a great medical advance, and the announced results from the STAR*D trial, heralded by the NIMH as the “largest and longest study ever done to evaluate depression treatment,” fit into that story of medical progress, for it told of 70% of depressed patients becoming “symptom free” after repeated treatments with antidepressants.

Self-awareness 145

Self-awareness Depression treatment 145

Mad in America

JANUARY 4, 2025

American psychiatry has weathered the crisis; it will not have to confront a public stunned by news of how the oft-cited 67% cumulative remission rate, in the largest and longest study ever done to evaluate depression treatment,” was born of scientific misconduct. Short of this, the best remaining course to take is a retraction.”

Pharmaceuticals 145

Pharmaceuticals Neurotransmitters and mental health Sleep and mental health Aging and mental health 145

Lightwork

FEBRUARY 20, 2025

Remember to document which prevention methods work best for you – this information becomes invaluable for managing symptoms in future seasons. Your provider will track the timing, duration, and severity of your symptoms through detailed questionnaires and personal interviews.

Sleep and mental health 52

Sleep and mental health Aging and mental health Cognitive Behavioral Therapy Mindfulness practices 52

Mad in America

JANUARY 3, 2024

However, there was recognition within the NIMH that that the industry-funded trials didn’t necessarily provide evidence of the efficacy of antidepressants in real-world patients, which prompted it to launch the STAR*D study, touting it as the “largest and longest study ever done to evaluate depression treatment.”

Neurotransmitters and mental health 144

Neurotransmitters and mental health Hospitality Education Self-awareness 144

Mad in America

JUNE 20, 2024

The eighties and nineties were a depression-treatment renaissance. James Davies in his book Cracked: the Unhappy Truth About Psychiatry, along with hundreds of papers over forty years, documented how members of the APA created most disorders with little, and in many cases, no empirically reviewed studies. billion worldwide.

Pharmaceuticals 139

Pharmaceuticals Manufacturing Construction Depression treatment 139

Mad in America

SEPTEMBER 18, 2024

Three other published critiques of the STAR*D study document this malfeasant reporting of the findings —all to no avail because psychiatry is in total control of the narrative. The second NIMH depression treatment study , which was published in 1992, reported on the long-term outcome of these drug treated patients.

Aging and mental health 145

Aging and mental health Cognitive Behavioral Therapy Manufacturing Anxiety disorders 145